No Data
Stephens & Co. Initiates Coverage On Catalyst Pharmaceuticals With Overweight Rating, Announces Price Target of $35
Catalyst Pharmaceuticals(CPRX.US) Director Sells US$3.1 Million in Common Stock
$Catalyst Pharmaceuticals(CPRX.US)$ Director MCENANY PATRICK J sold 137.16K shares of common stock on Nov 13, 14, 2024 at an average price of $22.579 for a total value of $3.1 million.Source:
Sentiment Still Eluding Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
Catalyst Pharmaceuticals(CPRX.US) Director Sells US$11.51 Million in Common Stock
$Catalyst Pharmaceuticals(CPRX.US)$ Director MCENANY PATRICK J sold 492K shares of common stock on Nov 11, 12, 2024 at an average price of $23.395 for a total value of $11.51 million.Source:
Catalyst Pharmaceuticals Recognized Among BioSpace 2025 Best Places to Work
Catalyst Pharmaceuticals' (NASDAQ:CPRX) Earnings May Just Be The Starting Point